Goldman Sachs Group Inc. Upgrades Henry Schein Inc. (HSIC) to “Buy”
Henry Schein Inc. (NASDAQ:HSIC) was upgraded by analysts at Goldman Sachs Group Inc. from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, The Fly reports.
HSIC has been the topic of several other reports. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Tuesday, September 20th. Bank of America Corp. started coverage on shares of Henry Schein in a report on Monday, September 12th. They issued a “buy” rating and a $185.00 price target on the stock. Finally, Robert W. Baird restated an “outperform” rating and issued a $176.00 target price (up from $175.00) on shares of Henry Schein in a report on Tuesday, October 4th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $157.92.
Henry Schein (NASDAQ:HSIC) opened at 163.04 on Tuesday. The company has a market cap of $13.34 billion, a PE ratio of 27.62 and a beta of 1.05. Henry Schein has a 12-month low of $140.11 and a 12-month high of $183.00. The stock has a 50 day moving average of $162.66 and a 200 day moving average of $170.44.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/11/goldman-sachs-group-inc-upgrades-henry-schein-inc-hsic-to-buy.html
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.63 by $0.01. The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.46 EPS. Equities analysts expect that Henry Schein will post $6.57 earnings per share for the current year.
In other Henry Schein news, Director Paul Brons sold 3,381 shares of the stock in a transaction on Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the transaction, the director now directly owns 13,715 shares of the company’s stock, valued at $2,249,671.45. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.27% of the company’s stock.
Institutional investors have recently bought and sold shares of the stock. Advisor Group Inc. acquired a new stake in shares of Henry Schein during the second quarter worth approximately $106,000. Global X Management Co. LLC boosted its stake in Henry Schein by 18.7% in the second quarter. Global X Management Co. LLC now owns 661 shares of the company’s stock valued at $117,000 after buying an additional 104 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in Henry Schein by 0.4% in the second quarter. Quadrant Capital Group LLC now owns 742 shares of the company’s stock valued at $128,000 after buying an additional 3 shares during the last quarter. Van ECK Associates Corp boosted its stake in Henry Schein by 29.1% in the second quarter. Van ECK Associates Corp now owns 727 shares of the company’s stock valued at $129,000 after buying an additional 164 shares during the last quarter. Finally, Mizuho Asset Management Co. Ltd. boosted its stake in Henry Schein by 108.6% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 1,018 shares of the company’s stock valued at $180,000 after buying an additional 530 shares during the last quarter. 91.98% of the stock is currently owned by institutional investors and hedge funds.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.